ATNM
#4356
Actinium Pharmaceuticals, Inc. Common Stock
0.9 7 USD
-0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-3.00%
Changement Mensuel
-25.95%
Evolution sur 6 mois
-15.65%
Changement Annuel
-6.73%
Clôture Précédente
1.0 0
Open
1.0 2
Low
0.9 7
High
1.0 2
Financials
- Market Capitalization 30.5 M
- Employee 25
- Founded 2000
- CEO Sandesh Seth
- Website www.actiniumpharma.com
- Headquarter Delaware, United States
- FIGI BBG000RQZ245
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.25
ratio cours/chiffre d'affaires
471.4
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4332 |  QNCX Quince Therapeutics, Inc. - Common Stock | 31.73 USD | 0.00% | +17.74% | +11.06% | +1527.18% | 32.27 M USD | ||
| 4336 |  GRDX GridAI Technologies Corp. - Common Stock | 4.50 USD | -1.10% | +6.38% | +55.71% | +76.47% | 32.09 M USD | ||
| 4361 |  CVM Cel-Sci Corporation Common Stock | 1.70 USD | -2.30% | -20.93% | +11.84% | -66.99% | 29.90 M USD | ||
| 4366 |  NXTC NextCure, Inc. - Common Stock | 6.43 USD | +2.39% | +1.42% | -3.31% | -50.92% | 29.43 M USD |